Effect of cognitive behaviour therapy on anxiety, depression and breathlessness in patients with Chronic Obstructive Pulmonary Disease

Not Applicable

Recruiting

• Conditions: Chronic obstructive pulmonary disease; depression; anxiety; Respiratory - Chronic obstructive pulmonary disease; Mental Health - Depression; Mental Health - Anxiety

• Registration Number: ACTRN12617000653369
• Lead Sponsor: Westmead hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-05-05
• Last Update Posted: 9 August 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

a) Severe or very severe COPD by Gold criteria (FEV1<60% predicted; FEV1/FVC ratio <70%).
b) Breathlessness (modified Medical Research Council dyspnea scale scores (mMRC > 2).
c) Completion of the Westmead Hospital Breathlessness Clinic within 9 months
d) Elevated anxiety or depression scores (Hospital Anxiety and Depression Scale - Anxiety score > 8 or Hospital Anxiety and Depression Scale - Depression score> 8).

Exclusion Criteria

a) A history of a recent (< 4 weeks) moderate to severe exacerbation of COPD, requiring hospitalisation.
b) Bed bound.
c) A diagnosis of dementia or cognitive impairment.
d) Insufficient proficiency in English for participation in CBT.
e) A current active diagnosis of cancer, other primary respiratory disease, substance abuse, other uncontrolled medical disorder.
f) Inability to comply with study procedures in the opinion of the investigators or the participant’s usual medical team
g) already receiving psychological intervention

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
change in Chronic Respiratory Questionnaire [baseline to 10 weeks];change Hospital Anxiety and Depression Scale [baseline to 10 weeks ]

Secondary Outcome Measures

Name	Time	Method
change in breathlessness numerical rating scales [baseline to 10 weeks];change in chronic obstructive pulmonary disease assessment test [baseline to 10 weeks];change in Dyspnea Management Questionnaire [baseline to 10 weeks];change in daily step count as measured by pedometer worn for 7 days[baseline to 10 weeks]